Piper Sandler analyst Adam Maeder lowered the firm’s price target on Intuitive Surgical (ISRG) to $580 from $620 and keeps an Overweight rating on the shares. The firm notes the company reported Q1 results that beat consensus on both the top and bottom-line. Piper was pleased to see both volume growth and placements exceed consensus estimates.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical: Strong Operating Momentum and Global Adoption Tailwinds Justify Buy Rating Despite Elevated Valuation
- Closing Bell Movers: Capital One, Interactive Brokers slip after results
- Intuitive Surgical says lower growth rate reflects ongoing China/Japan challenge
- Intuitive Surgical names new Chief Medical Officer
- Intuitive Surgical says ‘remain cautious’ on impact of subsidies under ACA